Metabolic Dysfunction–Associated Liver Disease Special Interest Group
Non-Alcoholic Fatty Liver Disease Special Interest Group
The Metabolic Dysfunction–Associated Liver Disease Special Interest Group (SIG) is linked to the Metabolic CRN topic area.
If anyone wishes to join the group please contact the BASL Secretariat on [email protected].
SIG Lead: Professor Matthew Armstrong, University Hospitals Birmingham
Mission
To understand, prevent and treat MASLD (previously known as NAFLD), and to reduce its impact on health as well as health services.
Aims
To promote and support the development, conduct and delivery of research activity related to MASLD.
To disseminate innovations and best practices in clinical services related to MASLD.
To involve patient representatives in the activities of the SIG.
To lead, contribute and participate in the development of educational activities related to MASLD.
To engage with pharma regarding research and educational activities related to MASLD.
To respond on behalf of BASL to national or international organisations on issues related to MASLD.
Quality standards for the management of MASLD
Overview
The BSG/BASL MASLD special interest group has developed a series of evidence-based quality standard recommendations, with the aim of improving the care of people with MASLD. It is known that MASLD is common, affecting 25% of the UK population and management of the condition is variable. Individuals with MASLD have an increased risk of overall mortality compared with the general population, and common causes of death include cardiovascular disease, malignancy and liver-related complications. A holistic approach is therefore needed to address liver disease, as well as cardio-metabolic risk factors.
The recommendations were developed using a modified Delphi process by a multidisciplinary group of 29 individuals from all disciplines involved in the management of people with MASLD, and cover: 1. Management of people with, or at risk of, MASLD before the gastroenterology or liver clinic; 2. Assessment and investigations in secondary care; 3. Management in secondary care. We have also developed 11 auditable key performance indicators (KPIs) to enable service to review the care of their patients and benchmark their practice.
Manuscript and summary documents
The full manuscript can be found here https://www.sciencedirect.com/science/article/pii/S2468125322000619?dgcid=author. (Free access to the manuscript will be available for 50 days from Friday 28 April 2022.)
Click here for the Download Summary of the NAFLD quality standard recommendations for website_l.pdf
MASLD-CARE: A National Implementation Audit of a MASLD Clinical Care Bundle in the UK - November 2026
The Yorkshire and Humber Gastroenterology Audit and Research Trainee Network (YaHGuT) is launching MASLD-CARE, a national multicentre quality improvement project. We are inviting hepatology and gastroenterology teams across the UK to participate.
The 2022 National NAFLD Audit identified significant variation in the quality of MASLD care across UK hospitals. MASLD-CARE aims to improve patient care by implementing standardized clinical care bundle and evaluating adherence to the 11 UK MASLD quality standards.
Participating centres will be asked to introduce MASLD care bundle into routine outpatient practice for at least three months, followed by a four-week retrospective audit of eligible new patients. All supporting documents, including the protocol, care bundle and instructions for local audit registration, will be provided.
We are now recruiting centres nationally! If you are interested in participating, please register your hospital using our online expression of interest form: https://docs.google.com/forms/d/e/1FAIpQLScSc3AbZPwPMn98TvcT2Z3ayuBETtJc0lsFSSIhTJlFL611tg/viewform
We encourage you to share this opportunity with your hepatology and gastroenterology colleagues and regional trainee research networks.
For further information, please contact the YaHGuT team at [email protected] .
Please view the full instuctions HERE
National study of NAFLD management identifies variation in delivery of care in the UK between 2019 to 2022 Audit results
Audit results: Download MASLD NATIONAL AUDIT.pdf
Resources and meeting downloads
SIG Meeting 16 May 2022 - Summary notes and presentations below.
Download NAFLD_Notes from SIG meeting 16th May 2022.pdf
Download 01_Introduction and NAFLD quality standards_2022 05_McPherson.pdf
Download 02_National NAFLD audit presentation_2022 05_Li.pdf
Download 03_NAFLD research update_2022 05_Corless.pdf
Download 04_Early detection of liver disease_2022 05_Andrew Yeoman.pdf
Download 05_NICE Type 2 DM update _2022 05_Byrne C.pdf
MASLD care bundle - Download NAFLD Outpatient Care bundle Gen Hep 11-1-19 - V2.1.docx
Use of the care bundle has been shown to improve the management of MASLD and the data was published in Frontline Gastroenterology journal.
MASLD bioresource
Philip Newsome, University of Brimingham - Download NAFLD BioResource_June 2019.pdf.
